H.R. 1384 · 117th Congress

Mainstreaming Addiction Treatment Act of 2021

Stage
In committee
Sponsor
Paul Tonko
Introduced
2021-02-25
Latest action
2021-04-28 · Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Summary

Mainstreaming Addiction Treatment Act of 2021

This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).

Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.

The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.